|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Other operating income | |||||
| Operating expenses | |||||
| Research and development | |||||
| General and administrative | |||||
| (Gain) / loss on foreign currency transactions | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Non-operating income / (expense) | |||||
| Loss on foreign currency transactions | |||||
| Gain / (loss) on foreign currency transactions | |||||
| Transaction costs allocable to warrants | |||||
| Change in fair value of the warrant liability | |||||
| Interest income | |||||
| Interest income / (expense) | |||||
| Total non-operating income / (expense) | |||||
| Loss before income taxes | |||||
| Income tax refund / (expense) | |||||
| Net loss | |||||
| Other comprehensive loss: | |||||
| Foreign currency translation | |||||
| Total comprehensive loss | |||||
| Preferred stock deemed dividends | |||||
| Net loss attributed to common stockholders | |||||
| Common share data: | |||||
| Basic net loss per common share (in dollars per share) | |||||
| Weighted average shares outstanding - basic (in shares) | |||||
| Diluted net loss per common share (in dollars per share) | |||||
| Weighted average shares outstanding -diluted (in shares) | |||||
| Dividends per common share (in dollars per share) | |||||
Loading...